Here are 10 key notes on orthopedic and spine device companies from the past week.
Hartford (Conn.) HealthCare is the first healthcare system in the state to utilize Caesarea, Israel-based Mazor Robotics’ Mazor X for spine surgeries.
Dublin, Ireland-based Medtronic announced the pricing of $2 billion-worth of senior notes.
Cambridge, Mass.-based InVivo Therapeutics announced the newest patient enrollee into its Inspire Study at Camden, N.J.-based Cooper Neurological Institute.
Zimmer Biomet led the $6.5 billion global hip replacement implant market in 2015.
Dublin, Ireland-based Mainstay Medical reported its full-year 2016 results, with its operating expenses totaling $16.8 million.
Caesarea, Israel-based Mazor Robotics is co-marketing and promoting its Mazor X technology with Medtronic.
Richard H. Bundschu, MD, of Bradenton, Fla.-based Coastal Orthopedics Sports Medicine & Pain Management, is a principal investigator for Nevro’s spinal cord stimulator study.
Houston-based Spine Injury Solutions, also known as SPIN, opened a Lubbock, Texas location as part of its affiliate expansion program.
Menlo Park, Calif.-based Asterias Biotherapeutics announced the sixth and final patient was administered AST-OPC1 after complete paralysis, and has exhibited positive signs following the six-month study.
Maple Grove, Minn.-based CVRx President and CEO Namid Yared was named chairman of Washington, D.C.-based AdvaMed’s board of directors.
More articles on devices:
Orthopedic, neurosurgery & cardiac fields spurring global medical robots market: 4 insights
Spine Injury Solutions expands — 5 things to know
Invivo announces 13th Inspire Study enrollee — 4 takeaways